|
POLH expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.14110000004608E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.85130000055034E-07 |
| Normal-vs-Stage2 |
3.580900E-03 |
| Normal-vs-Stage3 |
7.441600E-02 |
| Normal-vs-Stage4 |
6.645800E-01 |
| Stage1-vs-Stage2 |
1.354820E-01 |
| Stage1-vs-Stage3 |
7.406200E-01 |
| Stage1-vs-Stage4 |
8.737800E-03 |
| Stage2-vs-Stage3 |
6.245200E-01 |
| Stage2-vs-Stage4 |
1.020210E-02 |
| Stage3-vs-Stage4 |
1.218590E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.37969999991894E-07 |
| Normal-vs-AfricanAmerican |
5.777800E-03 |
| Normal-vs-Asian |
9.929400E-01 |
| Caucasian-vs-AfricanAmerican |
9.870000E-02 |
| Caucasian-vs-Asian |
1.231920E-02 |
| AfricanAmerican-vs-Asian |
7.682400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.24480000002403E-06 |
| Normal-vs-Female |
2.48369999999998E-05 |
| Male-vs-Female |
3.198400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.039300E-03 |
| Normal-vs-Extreme_Weight |
6.280500E-03 |
| Normal-vs-Obese |
7.95700000000288E-07 |
| Normal-vs-Extreme_Obese |
8.339900E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.019400E-01 |
| Normal_Weight-vs-Obese |
1.728030E-02 |
| Normal_Weight-vs-Extreme_Obese |
5.331200E-01 |
| Extreme_Weight-vs-Obese |
4.422000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.449000E-01 |
| Obese-vs-Extreme_Obese |
4.565800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.036500E-02 |
| Normal-vs-Age(41-60Yrs) |
4.564000E-04 |
| Normal-vs-Age(61-80Yrs) |
4.39500000004589E-06 |
| Normal-vs-Age(81-100Yrs) |
6.603600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.372400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.773800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.410100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.142600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.455800E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.375300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.3620000000002E-05 |
| Normal-VS-Type2 PRCC |
7.296200E-03 |
| Normal-VS-KIRP CIMP |
1.182180E-01 |
| Normal-VS-Unclassified PRCC |
6.799300E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.237400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.730000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.993400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.039600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.859200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.702400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.892400E-02 |
| Normal-vs-N1 |
1.536240E-01 |
| Normal-vs-N2 |
9.588600E-01 |
| N0-vs-N1 |
3.073000E-01 |
| N0-vs-N2 |
1.023170E-01 |
| N1-vs-N2 |
1.546950E-01 |
|
|
